Cerus (CERS) vs 908 Devices (MASS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cerus (CERS) has outperformed 908 Devices (MASS) over the past year, gaining 43.1% versus a gain of 32.2%. Over five years, CERS leads with a -62.6% price change compared with -63.2% for MASS. 908 Devices is the larger company by market cap ($479.3 million vs $452.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | MASS |
|---|---|---|
| Share price | $2.25 | $11.60 |
| Market cap | $452.42M | $479.26M |
| 1-day change | -1.97% | -1.57% |
| YTD return | +11.17% | +124.38% |
| 1-year return | +43.13% | +32.21% |
| 5-year return | -62.58% | -63.23% |
| EPS (TTM) | $-0.03 | $-0.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $13.35 |
| 52-week low | $1.38 | $5.03 |
| Distance from 52-week high | -35.30% | -13.13% |
| Analyst consensus | none | none |
| Avg. price target upside | +128.51% | +15.39% |
| Average volume | 2.13M | 404.42K |
| Shares outstanding | 201.52M | 41.33M |
| Employees | 261 | 172 |
| Sector | Health Care | Industrials |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed MASS by 10.9 percentage points over the past year.
- The two companies sit in different sectors: Cerus in Health Care and 908 Devices in Industrials.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
About 908 Devices
MASS stock →908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.
Industrials · Industrial Machinery/Components · 172 employees
CERS vs MASS FAQ
Which is bigger, Cerus or 908 Devices?
908 Devices (MASS) is larger, with a market capitalization of $479.26M compared with $452.42M for Cerus (CERS).
Which stock has performed better over the past year, CERS or MASS?
CERS returned +43.13% over the past 12 months, compared with +32.21% for MASS (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and 908 Devices in the same industry?
No. Cerus is in the Health Care sector, while 908 Devices is in Industrials.